Acceleron Pharma Inc (XLRN) Up 3.60% in Premarket Trading

Wednesday, November 17, 2021 07:16 AM | InvestorsObserver Analysts

Mentioned in this article

Acceleron Pharma Inc (XLRN) Up 3.60% in Premarket Trading

Acceleron Pharma Inc (XLRN) is up Wednesday morning, with the stock gaining 3.60% in pre-market trading to 180.25. XLRN's short-term technical score of 96 indicates that the stock has traded more bullishly over the last month than 96% of stocks on the market. In the Biotechnology industry, which ranks 137 out of 146 industries, XLRN ranks higher than 99% of stocks. Acceleron Pharma Inc has risen 0.60% over the past month, closing at $172.51 on October 20. During this period of time, the stock fell as low as $172.51 and as high as $174.89. XLRN has an average analyst recommendation of Sell. The company has an average price target of $179.30.

XLRN has an Overall Score of 72. Find out what this means to you and get the rest of the rankings on XLRN!

See Full XLRN Report

Acceleron Pharma Inc has a Long-Term Technical rank of 97. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 3% of the market scoring higher. In the Biotechnology industry which is number 139 by this metric, XLRN ranks better than 98% of stocks.

Important Dates for Investors in XLRN:

-Acceleron Pharma Inc is set to release earnings on 2/2/2022. During their last earnings release the company posted EPS of $-4.23. -We do not have a set dividend date for Acceleron Pharma Inc at this time. Click Here To Get The Full Report on Acceleron Pharma Inc (XLRN)